It aims to more than double in size by 2022 through a “combination of swift switching, new products, geographic expansion and smart acquisitions”.The company currently has a direct operational presence in 11 European countries and the US, with partnerships taking its products into more than 90 countries worldwide.HRA Pharma announced in April 2019 that it was acquiring global rights to the Mederma skincare brand from Merz Pharmaceuticals for an undisclosed sum.
Date Title Document; 12 Jun 2019: Amryt Pharma Annual Report 2018 : PDF : 26 Sep 2018: Interim Results Presentation : PDF : 26 Sep 2018: Interim Report 2018 : PDF : 2017. 12 March 2020 - Deborah Wilkes Privately-held HRA Pharma wants to be “one of the fastest-growing global consumer healthcare companies”. HRA is an innovative company, dedicated to creating added value products and solutions for consumers. Ketoconazole can still be found in topical medicines (medicines applied to the skin) to treat fungal infections. Regarding the EFPIA disclosure reports, please refer to the Global Methodological Note. There are 3 Directors associated with Hra Pharma Private Limited. As per the records of Ministry of Corporate Affairs (MCA), Hra Pharma Private Limited's last Annual General Meeting (AGM) was held on Sep 30, 2019, and the date of lastest Balance Sheet is Mar 31, 2019. Our Vision: To be a global leader in consumer health innovation.Believing that integrity is the basis of the longevity.Improving the lives of patients with rare diseases.The UN Global Compact reflects our long-standing commitment The Transparency reports include the transfers of values from HRA Pharma to HCPs and HCOs, as described in professionals Codes and applicable laws in each country.
HRA Pharma: Laboratoire HRA Pharma Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23082017 Prices from USD $250 SummaryLaboratoire HRA Pharma HRA Pharma is a healthcare products provider that offers women's health and endocrinology products. Further, M&A deals, expansion and asset purchase plans of the company are also detailed.
IAE Paris - Sorbonne Business School. The company said its Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) had increased by 30% compared to 2018. report. healthcare organisations. better understanding of how these collaborations that describes our disclosure Date Title Document; 30 Sep 2019: Amryt Pharma Interim Report 2019 : PDF : 2018. ('Richter') and Laboratoire HRA Pharma ('HRA Pharma') today announced that they concluded a sale and purchase agreement in connection with intellectual property rights of ulipristal acetate for the treatment of benign gynaecological disorders with respect to the territories of Latin America. Transparency Reports; Code of Ethics; UN Global Compact; Careers at HRA; Contact Us; Find Us; Our Products. for the countries where HRA Pharma has transfers of values to disclose.The Transparency reports include the transfers of values from HRA Pharma to Transparency Reports; Code of Ethics; UN Global Compact; Careers at HRA; Contact Us ; Find Us; Media Relations Please direct all media enquiries to: Adam Hodgkinson Head of Communication HRA Pharma Headquarters 200 avenue de Paris | 92320 Chatillon | France Email: Media_Relations@HRA-Pharma.com. Historically centered on women’s health, the company has become the European leader in emergency contraception. HRA Pharma’s products in your country: Regulatory status of the products may vary depending on the country. While we primarily focus on the field of women’s health and wound care, we also carefully monitor global consumers trends to identify new solutions which can improve people’s health and empower women and men around the world. innovative medicines and enhancing the quality of health education.